221 related articles for article (PubMed ID: 20473748)
1. Advance of studies on anti-atherosclerosis mechanism of berberine.
Wu M; Wang J; Liu LT
Chin J Integr Med; 2010 Apr; 16(2):188-92. PubMed ID: 20473748
[TBL] [Abstract][Full Text] [Related]
2. [Advance on study in anti-atherosclerosis mechanism of berberine].
Wu M; Wang J
Zhongguo Zhong Yao Za Zhi; 2008 Sep; 33(18):2013-6. PubMed ID: 19160773
[TBL] [Abstract][Full Text] [Related]
3. The Role of Berberine in the Multi-Target Treatment of Senile Dementia.
Huang M; Chen S; Liang Y; Guo Y
Curr Top Med Chem; 2016; 16(8):867-73. PubMed ID: 26311424
[TBL] [Abstract][Full Text] [Related]
4. Berberine metabolites could induce low density lipoprotein receptor up-regulation to exert lipid-lowering effects in human hepatoma cells.
Zhou Y; Cao S; Wang Y; Xu P; Yan J; Bin W; Qiu F; Kang N
Fitoterapia; 2014 Jan; 92():230-7. PubMed ID: 24321576
[TBL] [Abstract][Full Text] [Related]
5. Combination of berberine and evodiamine inhibits intestinal cholesterol absorption in high fat diet induced hyperlipidemic rats.
Zhou X; Ren F; Wei H; Liu L; Shen T; Xu S; Wei J; Ren J; Ni H
Lipids Health Dis; 2017 Dec; 16(1):239. PubMed ID: 29228954
[TBL] [Abstract][Full Text] [Related]
6. Lipid-lowering effect of berberine in human subjects and rats.
Hu Y; Ehli EA; Kittelsrud J; Ronan PJ; Munger K; Downey T; Bohlen K; Callahan L; Munson V; Jahnke M; Marshall LL; Nelson K; Huizenga P; Hansen R; Soundy TJ; Davies GE
Phytomedicine; 2012 Jul; 19(10):861-7. PubMed ID: 22739410
[TBL] [Abstract][Full Text] [Related]
7. Traditional chinese medicine in treatment of metabolic syndrome.
Yin J; Zhang H; Ye J
Endocr Metab Immune Disord Drug Targets; 2008 Jun; 8(2):99-111. PubMed ID: 18537696
[TBL] [Abstract][Full Text] [Related]
8. Tracking evidences of Coptis chinensis for the treatment of inflammatory bowel disease from pharmacological, pharmacokinetic to clinical studies.
Yang Y; Vong CT; Zeng S; Gao C; Chen Z; Fu C; Wang S; Zou L; Wang A; Wang Y
J Ethnopharmacol; 2021 Mar; 268():113573. PubMed ID: 33181286
[TBL] [Abstract][Full Text] [Related]
9. Biological properties and clinical applications of berberine.
Song D; Hao J; Fan D
Front Med; 2020 Oct; 14(5):564-582. PubMed ID: 32335802
[TBL] [Abstract][Full Text] [Related]
10. ¹H-NMR-Based Metabonomics of the Protective Effect of Coptis chinensis and Berberine on Cinnabar-Induced Hepatotoxicity and Nephrotoxicity in Rats.
Su G; Wang H; Gao Y; Chen G; Pei Y; Bai J
Molecules; 2017 Nov; 22(11):. PubMed ID: 29099071
[No Abstract] [Full Text] [Related]
11. Effects of berberine in the gastrointestinal tract - a review of actions and therapeutic implications.
Chen C; Yu Z; Li Y; Fichna J; Storr M
Am J Chin Med; 2014; 42(5):1053-70. PubMed ID: 25183302
[TBL] [Abstract][Full Text] [Related]
12. Berberine and Its Role in Chronic Disease.
Cicero AF; Baggioni A
Adv Exp Med Biol; 2016; 928():27-45. PubMed ID: 27671811
[TBL] [Abstract][Full Text] [Related]
13. Berberine and Coptidis rhizoma as novel antineoplastic agents: a review of traditional use and biomedical investigations.
Tang J; Feng Y; Tsao S; Wang N; Curtain R; Wang Y
J Ethnopharmacol; 2009 Oct; 126(1):5-17. PubMed ID: 19686830
[TBL] [Abstract][Full Text] [Related]
14. [Research progress on medicinal resources of Coptis and its isoquinoline alkaloids].
Wang AQ; Yuan QJ; Guo N; Yang B; Sun Y
Zhongguo Zhong Yao Za Zhi; 2021 Jul; 46(14):3504-3513. PubMed ID: 34402272
[TBL] [Abstract][Full Text] [Related]
15. Fractionated
Lee JW; Kang YJ; Choi HK; Yoon YG
J Microbiol Biotechnol; 2018 Jun; 28(6):839-848. PubMed ID: 29642289
[No Abstract] [Full Text] [Related]
16. Berberine: A Promising Natural Isoquinoline Alkaloid for the Development of Hypolipidemic Drugs.
Li DD; Yu P; Xiao W; Wang ZZ; Zhao LG
Curr Top Med Chem; 2020; 20(28):2634-2647. PubMed ID: 32901585
[TBL] [Abstract][Full Text] [Related]
17. Berberine and Coptidis Rhizoma as potential anticancer agents: Recent updates and future perspectives.
Wang N; Tan HY; Li L; Yuen MF; Feng Y
J Ethnopharmacol; 2015 Dec; 176():35-48. PubMed ID: 26494507
[TBL] [Abstract][Full Text] [Related]
18. Jatrorrhizine hydrochloride attenuates hyperlipidemia in a high-fat diet-induced obesity mouse model.
Yang W; She L; Yu K; Yan S; Zhang X; Tian X; Ma S; Zhang X
Mol Med Rep; 2016 Oct; 14(4):3277-84. PubMed ID: 27573054
[TBL] [Abstract][Full Text] [Related]
19. Exploration of anti-cancer effects and mechanisms of Zuo-Jin-Wan and its alkaloid components in vitro and in orthotopic HepG2 xenograft immunocompetent mice.
Chou ST; Hsiang CY; Lo HY; Huang HF; Lai MT; Hsieh CL; Chiang SY; Ho TY
BMC Complement Altern Med; 2017 Feb; 17(1):121. PubMed ID: 28219365
[TBL] [Abstract][Full Text] [Related]
20. Berberine, a Herbal Metabolite in the Metabolic Syndrome: The Risk Factors, Course, and Consequences of the Disease.
Och A; Och M; Nowak R; Podgórska D; Podgórski R
Molecules; 2022 Feb; 27(4):. PubMed ID: 35209140
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
